SenesTech, Inc. reported a net revenue of $2.2 million for the fiscal year ending December 31, 2025, marking a 20% increase from $1.9 million in 2024. This growth was primarily driven by the strong performance of the Evolve product line, which accounted for approximately 81% of total revenue, up from 66% the previous year. The company’s gross profit also improved, reaching $1.4 million with a gross margin of 62.5%, compared to $1.0 million and a 54.1% margin in 2024. Despite these gains, SenesTech reported a net loss of $6.4 million, slightly higher than the $6.2 million loss in the prior year, attributed to increased operating expenses.
In terms of operational developments, SenesTech has expanded its product offerings with the launch of Evolve Mouse in May 2024, following the introduction of Evolve Rat in January 2024. The company has successfully registered Evolve Rat in 48 states and Evolve Mouse in 37 states, enhancing its market presence. The total employee count as of December 31, 2025, was 24, reflecting a stable workforce as the company continues to focus on product development and commercialization efforts.
The filing indicates that SenesTech is actively pursuing international markets and has begun marketing its Evolve products through distributors. The company is also focused on optimizing its sales channels, particularly in e-commerce and retail, to further drive revenue growth. However, the company faces challenges, including the need for additional capital to fund ongoing operations and product development, as it has incurred significant operating losses since inception.
Looking ahead, SenesTech anticipates that its cash reserves, combined with projected revenues, will be sufficient to support operations through the second quarter of 2027. The company is exploring various financing options, including equity offerings and strategic partnerships, to bolster its financial position. Management remains optimistic about the market potential for non-lethal rodent control solutions, driven by increasing regulatory scrutiny of traditional rodenticides and a growing demand for sustainable pest management alternatives.
About SenesTech, Inc.
Senestech, Inc. develops and commercializes non-lethal fertility control products for managing rodent populations, primarily rats and mice. Its key offerings, ContraPest and Evolve, target reproductive systems to reduce pest numbers sustainably. The company operates in the pest management industry, emphasizing environmentally safe, minimally invasive solutions that complement integrated pest management programs, with a focus on regulatory compliance and market adoption.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.